Scientific Aim

The Landsteiner Foundation for Blood Transfusion Research (LSBR) supports clinical and experimental scientific research in the field of blood, blood-forming tissue, blood products, and blood (related) diseases, provided that the research bears a relationship to the field of transfusion or transplantation of blood cells.


In 1948 the Dutch government, the Dutch Red Cross and the municipality of Amsterdam founded the Central Laboratory of the Blood Transfusion Service of the Netherlands Red Cross (CLB) and installed its supporting foundation the “Stichting tot Instandhouding van het CLB” (StICLB). This foundation supported activities of CLB by providing loans to CLB for investments, renting offices and lab space to CLB and funding CLB research projects. Its board acted as the supervisory board of CLB.
In 1998 CLB merged with the 22 Dutch regional blood banks into a new foundation, i.e. Sanquin Blood Supply Foundation. Because of this merger the statutes of StICLB needed to be adapted, to ensure that the (financial) assets of StICLB remained available for continued support of the “CLB activities” in order that CLB remained the national and international scientific expertise centre in blood transfusion. The name of StICLB was changed to “Landsteiner Stichting voor Bloedtransfusieresearch” (LSBR).

Article 3 of the LSBR statutes of 17 April 2015 specifies the objectives of LSBR:

The budget for research grants can fluctuate from year to year, depending on the investment results. On average the LSBR is able to support up to 7 projects each year. For the year 2018 LSBR had a budget of € 2.3 million enabling to support 5 projects out of the 22 full applications received.
Since 1999, LSBR has been reviewing and selecting project proposals on transfusion research and has been able to grant over 100 research projects so far.
For an overview of the projects till 2019, please see: list of LSBR projects